Product information
of REVOLAX Fine
REVOLAX Fine Lidocaine is designed for the treatment of superficial wrinkles, including crow's feet, frown lines, and neck wrinkles. It penetrates quickly into the skin, creating a very natural and healthier look for the injected area.
Treatment of superficial wrinkles
Facial Volumeizing
Superficial lines
Crow’s Feet
Neck Wrinkles
Frown lines
Needle : 30G
Injection depth : Superficial to top dermis
Type : Monophasic
Ingredients : Hyaluronic acid, Lidocaine
HA Composition : 24mg/ml
Lidocaine : 0.3%
Complex Viscosity : 80
Aesthetic effect : 8 – 12 Months
Packaging : 1.1ml syringe / 2 needles
Storage : 2~25˚C
REVOLAX™ is bio-degradable gel that uses hyaluronic acid with high purity from bacterial fermentation. It is natural substance optimized to suit with human skin tissue.
Our unique cross linking technology does not need adding free Hyaluronic acid to adjust physical property of the gel.
Visco-elasticity is one of the most critical elements that determine longevity. Volume effect and molding ability of the gel has been optimized by level of visco-elasticity per product according to use and treatment area. REVOLAX™ makes sure longer lasting and stronger support for skin structure.
REVOLAX™ is made of regular and dense monophasic structure. The consistency of the pattern ensures not only naturally harmonized volume but easy and comfortable injection for both surgeons and patients.
- By using Ultra Thin Wall needle, soft injection is available and helpful to minimize pop off.
- Due to uniform monophasic structure, REVOLAX™ can be properly injected without free HA.
** Ref. Data on file. Across
** Injection should be taking not just less force but consistent force as well.
Efficacy and Safety of REVOLAX™™ Sub-Q with Lidocaine-Clinical Study Result (NCT02179606)
Multi-Center, Randomized, Subject and Evaluator Blind, Split-Face, Comparative (24-Weeks)
60 Subjects with confirmed WSRS(Wrinkle Severity Rating Scale) Grade 3 or 4 nasolabial folds who want correction
Comparison of the means of WSRS* in Week 24
Evaluation of the overall aesthetic results by the investigators and the subjects (Calculated from GAIS)
Result: Mean WSRS* scores assessed at week 24 of REVOLAX are lower than those of A filler group. *The Wrinkle Severity Rating Scale(WSRS)
Result: Both investigators and subjects were satisfied highly with the effect of the REVOLAX "group for 6months. *Global Aesthetic Improvement Scale. (GAIS)
